TITLE

Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management

AUTHOR(S)
Abdel-Hady, Mona; Kelly, Deirdre
PUB. DATE
August 2013
SOURCE
Pediatric Drugs;2013, Vol. 15 Issue 4, p311
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hepatitis B virus (HBV) infection is a worldwide health problem, which can cause acute liver failure, acute hepatitis, chronic hepatitis, liver cirrhosis, and liver cancer. It is most prevalent in Asia, Africa, Southern Europe, and Latin America. Approximately 2 billion people in the world have been infected by HBV, with more than 350 million as chronic carriers. Implementation of the HBV vaccine led to a significant reduction in viral transmission in many areas of the world; however, it remains highly endemic in many developing countries. The main source of infection in childhood is via perinatal transmission or horizontal transmission during preschool years. The majority of children with chronic hepatitis B (CHB) infection are asymptomatic; however, they may develop progressive disease and are at increased risk of advanced liver disease or liver cancer before their third decade. All children with chronic HBV infection should be regularly monitored for disease progression. The goal of therapy for children with CHB is to arrest disease progression and reduce the risk of developing cirrhosis and cancer. The available medications have a low success rate because of immunotolerance in the child and the development of viral resistance to standard therapy. Therefore, case selection and determination of the best time to commence treatment are essential to increase treatment efficacy and reduce the risk of viral resistance.
ACCESSION #
89151476

 

Related Articles

  • Management of chronic hepatitis B infection. Sundaram, Vinay; Kowdley, Kris V. // BMJ: British Medical Journal;11/7/2015, Vol. 351 Issue 8032, ph4263 

    Hepatitis B virus (HBV) is a global health problem that can lead to cirrhosis and hepatocellularcarcinoma (HCC). Although HBV vaccination has reduced the prevalence of HBV infection, the burden of disease remains high. Treatment with antiviral drugs reduces the risk of liver disease and the...

  • Management of chronic hepatitis B infection. Davison, Suzanne // Archives of Disease in Childhood;Nov2014, Vol. 99 Issue 11, p1037 

    The spectrum of chronic hepatitis B infection in children ranges from asymptomatic carriage with minimal disease, to progression to cirrhosis and risk of hepatocellular carcinoma in adulthood. Identifying those who will benefit from treatment is a challenge. Interferon-based therapies have...

  • Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end? Michel, Marie-Louise; Bourgine, Maryline; Fontaine, Hélène; Pol, Stanislas // Medical Microbiology & Immunology;Feb2015, Vol. 204 Issue 1, p121 

    The antiviral treatment of chronic hepatitis B virus (HBV) infection has greatly improved over the last 20 years since it has allowed a disappearance of cirrhosis decompensation and a significant reduction of the incidence of hepatocellular carcinoma. However, a complete HBV cure has not been...

  • Classification and Progression Based on CFS-GA and C5.0 Boost Decision Tree of TCM Zheng in Chronic Hepatitis B. Xiao Yu Chen; Li Zhuang Ma; Na Chu; Min Zhou; Yiyang Hu // Evidence-based Complementary & Alternative Medicine (eCAM);2013, Vol. 2013, p1 

    Chronic hepatitis B (CHB) is a serious public health problem, and Traditional Chinese Medicine (TCM) plays an important role in the control and treatment for CHB. In the treatment of TCM, zheng discrimination is the most important step. In this paper, an approach based on CFS-GA (Correlation...

  • Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions. Jae-Jun Shim // Gut & Liver;May2015, Vol. 9 Issue 3, p265 

    The author reflects on a study which investigates the effect of long-term antiviral therapy of viral replication in chronic hepatitis B (CHB) patients. Topics discussed include the disease progression, cost-effectiveness of the treatment, and DNA levels among patients. Information regarding the...

  • Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review. Buti, Marıa; Oyagüez, Itziar; Lozano, Virginia; Casado, Miguel A. // PharmacoEconomics;2013, Vol. 31 Issue 1, p63 

    Background Chronic hepatitis B is a common, progressive disease, particularly when viral replication is detected. Oral antivirals can suppress viral replication and prevent or delay the development of cirrhosis and liver-related complications. Objective The aim of this study was to...

  • Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy. Jin Chang Moon; Seong Hun Kim; In Hee Kim; Chang Hun Lee; Sang Wook Kim; Seung Ok Lee; Soo Teik Lee; Dae-Ghon Kim // Gut & Liver;May2015, Vol. 9 Issue 3, p395 

    Background/Aims: We investigated factors associated with the disease progression and development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients during long-term oral nucleos(t)ide analog (NA) therapy. Methods: This retrospective study included 524 naive CHB patients who...

  • The importance of a preschool booster for children born to hepatitis B-positive mothers. Ladhani, Shamez N.; Ramsay, Mary E. // Archives of Disease in Childhood;Jun2013, Vol. 98 Issue 6, p395 

    The author focuses on the chronic hepatitis B virus (HBV) infection which is associated with cirrhosis, hapatic failure and hepatocellular carcinoma. He reports that the World Health Organization (WHO) has recommended the childhood hepatitis B immunization at birth. He mentions about the...

  • Correlation between Th17 and nTreg cell frequencies and the stages of progression in chronic hepatitis B. CHUN YANG; FANG CUI; LI-MIN CHEN; XUE-YAN GONG; BO QIN // Molecular Medicine Reports;2016, Vol. 13 Issue 1, p853 

    Several studies have suggested that the balance of T helper 17 (Th17) and natural regulatory T (nTreg) cells in the Th17-mediated immune response are critical in the pathogenesis of viral hepatitis. The aim of the present study was to examine the role of circulating Th17 and nTreg cells in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics